Skip to content
lifestyle.nextmentors.com
Animals
Auto
Beauty & Style
Business News
Entertainment
Food
Health
Home & Family
Podcasts
Tech
Travel
Author:
JenaValve Technology, Inc.
JenaValve Appoints Edward Sarnowski as Chief Technology Officer
May 27, 2026
JenaValve Appoints Tonya Porter as Vice President of Regulatory Affairs
May 21, 2026
JenaValve Appoints Dave Haan as Vice President of Clinical Affairs
May 12, 2026
JenaValve Announces the Start of Commercialization of the Trilogy® Transcatheter Heart Valve System in the United States – the First and Only Transcatheter Device Approved for Symptomatic, Severe Aortic Regurgitation (ssAR)
April 1, 2026
JenaValve Announces FDA Approval of the Trilogy™ Transcatheter Heart Valve System — the First and Only Transcatheter Device Approved for Symptomatic, Severe Aortic Regurgitation (ssAR) in the United States
March 18, 2026
JenaValve Appoints John Molyneux to Vice President of Operations
January 29, 2026